Table 2.
Target Organ | Model | Exposure | Observed Changes | Reference |
---|---|---|---|---|
Liver | Various | Various | Hepatic inflammation; activation of Kupffer cells and hepatic stellate cells; centrilobular apoptosis and necrosis; cytoplasmic vacuolization; cytoskeletal reorganization; hepatocyte blebbing; hepatocarcinogenesis. | [115,116,117], https://doi.org/10.1293/tox.14.259 (accessed on 10 April 2023), [118] |
Kidney | Adult male Wistar rats | Chronic, sub-lethal dose, administered intraperitoneally | Glomerular collapse with thickening of the basement membrane; renal tubules showed actin condensation, appeared dilated and filled with proteinaceous casts; increased apoptotic cells in renal cortex and medulla. | [119] |
Brain | Adult male BALB/c mice | Chronic sub-lethal dose, administered orally via drinking water | Disruption of blood–brain barrier function; neuroinflammation; microglial and astrocyte activation. | [120] |
Lung | Specific-pathogen-free female BALB/C mice | Chronic low dose, administered orally in drinking water | Alveolar collapse and thickening of alveolar septum; slight increase cellular apoptosis at a higher dose; loss of epithelial barrier function. | [121] |
Heart | Adult Wistar rats | Chronic | Increased size of cardiomyocytes; reduced myofibril volume fraction; fibrosis; mononuclear infiltration in interstitial spaces. |
[122] |